Premium Information is available for this item - Upgrade for $1 a day

6505-01-164-0576

Nitroglycerin Transdermal System

6505011640576 011640576 NDC00369-0310-01 NITRO-DUR 10

6505-01-164-0576 NITROGLYCERIN TRANSDERMAL SYSTEM 6505011640576 011640576

Managed by United States
NSN Created on 12 Oct 1983
Data Last Changed
January 2023
NATO Update Count
8
NATO Data Quality
6505-01-164-0576 NITROGLYCERIN TRANSDERMAL SYSTEM 6505011640576 011640576 1/1
NSN 6505-01-164-0576 (Generic Image) 1/1

6505-01-164-0576 Stock and Availability Marketplace 6505-01-164-0576

Need Help?
Request a Quotation from participating marketplace vendors
eBay Updated Every Day
6505-01-164-0576 RQST NE eBay
eBay Updated Every Day
6505-01-164-0576 RQST eBay
Amazon Updated Every Day
6505-01-164-0576 RQST NE Amazon

6505-01-164-0576 Related Documents Related Documents 6505-01-164-0576 5+ Documents (More...)

Nitroglycerin Transdermal System 011640576 143-0758 6505-01-396-1314 www.nsnlookup.com /fsg-65/
011640576 NDC00369-0310-01 NITRO-DUR NumberManufacturerStatusNDC00369-0310-01 24214 - Key Pharmaceuticals
Inc (Obsolete) Original Design RNCC 3 RNVC 9 DAC 6 NITRO-DUR Stock Numbers Related to 6505-01-164-0576
Pharmaceuticals Inc in Miami, FL United States https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-164-0576
Nitroglycerin Transdermal System 011640576 Upgrade 6505-01-164-0576Nitroglycerin Transdermal System6505011640576
011640576 NDC00369-0310-01 NITRO-DUR NumberManufacturerStatusNDC00369-0310-01 24214 - Key Pharmaceuticals
Pharmaceuticals Inc in Miami, FL United States https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-164-0576
Nitroglycerin Transdermal System 011640576 Upgrade 6505-01-164-0576Nitroglycerin Transdermal System6505011640576
011640576 NDC00369-0310-01 NITRO-DUR NumberManufacturerStatusNDC00369-0310-01 24214 - Key Pharmaceuticals
6505-27-004-0589 6505/us 6505-01-164-0576 Nitroglycerin Transdermal System 011640576 164-0576 6505
6505-27-004-0589 Design RNCC 3 RNVC 9 DAC 6 NITRO-DUR Stock Numbers Related to 6505-01-164-0576
6505-01-164-0576 6505-27-004-0589 Navy Cognizance:9L NATO Stock Numbers Related to 6505-01-396-1314
Tablets THEO-DURRNCC: 5 | RNVC: 1 | DAC: 4NDC00085-0933-81RNCC: 3 | RNVC: 9 | DAC: 4 27 Apr 1980 6505-01-164-0576

6505-01-164-0576 Demil Restrictions 6505-01-164-0576

DEMIL: A | DEMILI: 1 | CRITICALITY: X | HMIC: P | PMIC: U | EDC: | ADPEC:

6505-01-164-0576 is a Nitroglycerin Transdermal System that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.

6505-01-164-0576 HTS and ScheduleB Import and Export 6505-01-164-0576

6505-01-164-0576 End Users End Users 6505-01-164-0576

MOE Rule:
V540
Effective Date:
1 Apr 1991
United States of America (ZZ)

6505-01-164-0576 Manufacturers Approved Sources 6505-01-164-0576

6505-01-164-0576 Technical Data Datasheet 6505-01-164-0576

Characteristic
Specifications
FIIG
A510W0
Usual Dose [CSLZ]
5 Mg Released Per 24 Hours
Overall Strength In System [CYMT]
51 Mg Per System

6505-01-164-0576 Related Items NATO Stock Numbers Related to 6505-01-164-0576

6505-01-164-0576 Freight Data Freight Information 6505-01-164-0576

6505-01-164-0576 has freight characteristics.. 6505-01-164-0576 has a variance between NMFC and UFC when transported by rail and the description should be consulted.